Spring til hovednavigation Spring til søgning Spring til hovedindhold

Screening for lung cancer: are we there yet?

  • Maurizio V Infante
  • , Jesper H Pedersen
    14 Citationer (Scopus)

    Abstract

    In lung cancer screening with low-dose spiral computed tomography (LDCT), the proportion of stage I disease is 50-85%, and the survival rate for resected stage I disease can exceed 90%, but proof of real benefit in terms of lung cancer mortality reduction must come from the several randomized trials underway in Europe and in the USA. Our purpose is to update the readers on recent progress in medical knowledge in this field.
    OriginalsprogEngelsk
    TidsskriftCurrent Opinion in Pulmonary Medicine
    Vol/bind16
    Udgave nummer4
    Sider (fra-til)301-6
    Antal sider6
    ISSN1070-5287
    DOI
    StatusUdgivet - 2010

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Screening for lung cancer: are we there yet?'. Sammen danner de et unikt fingeraftryk.

    Citationsformater